UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 13, 2012

 

SYMMETRY MEDICAL INC.

(Exact name of Registrant as specified in its charter)

 

 

Delaware   001-32374   35-1996126

(State or other jurisdiction

of incorporation)

   (Commission File Number)  

(IRS Employer

Identification No.)

 

3724 N State Road 15, Warsaw, Indiana 46582

(Address of Principal executive offices, including Zip Code)

 

(574) 268-2252

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 8.01.     Other Events

 

On March 13, 2012 Symmetry Medical Inc. (“the Company”) released a press release entitled, “Symmetry Medical to Present at the Sidoti & Company 16th Annual Institutional Investor Forum,” in which the Company announced that it will present at the Sidoti & Company 16th Annual Institutional Investor Forum in New York City. The conference is scheduled to take place on Tuesday, March 20, 2012, and the Company will present at 10:00 am ET. Further details are included in the press release, which is being furnished as Exhibit 99.1.

 

Item 9.01.  Financial Statements and Exhibits

 

 

(d)  Exhibits

 

99.1 “Symmetry Medical to Present at the Sidoti & Company 16th Annual Institutional Investor Forum,” Press Release issued by Symmetry Medical, Inc. dated March 13, 2012.

 

________________

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Symmetry Medical Inc.
   
  /s/ Fred L. Hite
Date: March 13, 2012 Name:  Fred L. Hite
  Title:    Chief Financial Officer

 

 

 

EXHIBIT INDEX

  

Exhibit No. Description
99.1 “Symmetry Medical to Present at the Sidoti & Company 16th Annual Institutional Investor Forum,” Press Release issued by Symmetry Medical, Inc. dated March 13, 2012.